Hashim H, Blanker MH, Drake MJ, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019; 38:499–508.
Andersson F, Anderson P, Holm-Larsen T, Piercy J, Everaert K, Holbrook T. Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults. J Med Econ. 2016;19:1200–6. https://doi.org/10.1080/13696998.2016.1211136.
Tikkinen KAO, Johnson TM, Tammela TLJ, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–98..
Vaughan CP, Fung CH, Huang AJ, Johnson TM, Markland AD. Differences in the association of nocturia and functional outcomes of sleep by age and gender: a cross-sectional, population-based study. Clin Ther. 2016;38:2386–93.e1.
Article PubMed PubMed Central Google Scholar
Pauwaert K, Bruneel E, van Laecke E, Depypere H, Everaert K, Goessaert AS. Does hormonal therapy affect the bladder or the kidney in postmenopausal women with and without nocturnal polyuria: results of a pilot trial? Maturitas. 2022;160:61–7.
Article CAS PubMed Google Scholar
Everaert K, Hervé F, Bosch R, et al. International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourol Urodyn. 2019;38:478–98. https://doi.org/10.1002/nau.23939.
Varella LRD, Bezerra da Silva R, Eugênia de Oliveira MC, et al. Assessment of lower urinary tract symptoms in different stages of menopause. J Phys Ther Sci. 2016;28:3116–21.
Article PubMed PubMed Central Google Scholar
Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:1.
Hsu A, Nakagawa S, Walter LC, et al. The burden of nocturia among middle-aged and older women. Obstet Gynecol. 2015;125:35–43.
Article PubMed PubMed Central Google Scholar
Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genito-urinary tract. Maturitas. 1992;15:101–11.
Article CAS PubMed Google Scholar
Srisukho S, Pantasri T, Piyamongkol W, Phongnarisorn C, Morakote N. The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. Int Urogynecol J. 2019;30:1843–7.
Jones HJ, Huang AJ, Subak LL, Brown JS, Lee KA. Bladder symptoms in the early menopausal transition. J Womens Health (Larchmt). 2016;25:457–63.
Tikkinen KAO, Auvinen A, Tiitinen A, Valpas A, Johnson TM, Tammela TLJ. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol. 2008;199:153.e1–12.
Tikkinen KAO, Johnson TM, Tammela TLJ, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–96.
Asplund R, Åberg HE. Nocturia and health in women aged 40–64 years. Maturitas. 2000;35:143–8.
Article CAS PubMed Google Scholar
Chen YC, den Chen G, Hu SW, Lin TL, Lin LY. Is the occurrence of storage and voiding dysfunction affected by menopausal transition or associated with the normal aging process? Menopause. 2003;10:203–8.
Pauwaert K, Goessaert A-S, Ghijselings L, Bower W, Depypere H, Everaert K. Characterizing nocturia among Belgian healthy postmenopausal women: prevalence, bother, etiology and possible risk factors for developing nocturia. Maturitas. 2020;143:41–6.
Terauchi M, Hirose A, Akiyoshi M, Owa Y, Kato K, Kubota T. Prevalence and predictors of storage lower urinary tract symptoms in perimenopausal and postmenopausal women attending a menopause clinic. Menopause. 2015;22:1084–90.
Nakagawa H, Niu K, Hozawa A, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184:1413–8.
Tang R, Fan Y, Luo M, et al. General and central obesity are associated with increased severity of the VMS and sexual symptoms of menopause among Chinese women: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:814872.
Hetemäki N, Savolainen-Peltonen H, Tikkanen MJ, et al. Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women. J Clin Endocrinol Metab. 2017;102:4588–95.
Lizcano F. Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes. Front Endocrinol (Lausanne). 2022;13:921504.
Pauwaert K, Goessaert A-S, Ghijselings L, et al. Hormone therapy as a possible solution for postmenopausal women with nocturia. Menopause. 2021;28:502–10.
Everaert K, Hervé F, Bower W, Djurhuus JC, Dmochowski R, Fine N, et al. How can we develop a more clinically useful and robust algorithm for diagnosing and treating nocturia? ICI-RS 2017. Neurourol Urodyn. 2018;37:S46–59.
Bower WF, Rose GE, Whishaw DM, Ervin CF, Wang AC, Moore KH. The association between nocturia, hormonal symptoms and bladder parameters in women: an observational study. BJOG. 2022;129:812–9.
Article CAS PubMed Google Scholar
Leimola-Virtanen R, Salo T, Toikkanen S, Pulkkinen J, Syrjänen S. Expression of estrogen receptor (ER) in oral mucosa and salivary glands. Maturitas. 2000;36:131–7.
Article CAS PubMed Google Scholar
Minicucci EM, Pires RBC, Vieira RA, Miot HA, Sposto MR. Assessing the impact of menopause on salivary flow and xerostomia. Aust Dent J. 2013;58:230–4.
Article CAS PubMed Google Scholar
Asplund R, Åberg HE. Oral dryness, nocturia and the menopause. Maturitas. 2005;50:86–90.
Chagnac A. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480–6. https://doi.org/10.1097/01.ASN.0000068462.38661.89.
Cardozo L, Robinson D, Dmochowski RR, et al. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder. Urology. 2002;60:64–71; discussion 71.
Blümel JE, Chedraui P, Baron G, et al. Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric. 2012;15:542–51.
Portman DJ, Gass MLS, Kingsberg S, et al. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21:1063–8.
Robinson D, Toozs-Hobson P, Cardozo L. The effect of hormones on the lower urinary tract. Menopause Int. 2013;19:155–62.
Pfisterer MH-D, Griffiths DJ, Rosenberg L, Schaefer W, Resnick NM. Parameters of bladder function in pre-, peri-, and postmenopausal continent women without detrusor overactivity. Neurourol Urodyn. 2007;26:356–61.
Parsons M, Amundsen CL, Cardozo L, Vella M, Webster GD, Coats AC. Bladder diary patterns in detrusor overactivity and urodynamic stress incontinence. Neurourol Urodyn. 2007;26:800–6. https://doi.org/10.1002/nau.20406.
Hristov KL, Parajuli SP, Provence A, Rovner ES, Petkov GV. Nongenomic modulation of the large conductance voltage- and Ca2+-activated K+ channels by estrogen: a novel regulatory mechanism in human detrusor smooth muscle. Physiol Rep. 2017;5:e13351.
Article PubMed PubMed Central Google Scholar
Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol. 2002;160:1877–85.
Article CAS PubMed PubMed Central Google Scholar
Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001;12:241–51.
Article CAS PubMed Google Scholar
Oelkers WHK. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric. 2005;8:19–27. https://doi.org/10.1080/13697130500330341.
Article CAS PubMed Google Scholar
Forsling ML, Akerlund M, Stromberg P. Variations in plasma concentrations of vasopressin during the menstrual cycle. J Endocrinol. 1981;89:263–6.
Comments (0)